|
Clinical variables
|
Clinical outcomes
|
P
|
OR/HR (95% CI)
|
|---|
|
Risk stratifications
|
OS (mean day ± SE)
|
0.027
| |
|
Low + intermediate
|
1473 ± 82
| |
1.00 (reference)
|
|
High
|
1048 ± 113
| |
2.325 (1.103–4.900)
|
|
Risk stratifications
|
PFS (mean day ± SE)
|
0.013
| |
|
Low
|
1532 ± 151
| |
1.00 (reference)
|
|
Intermediate
|
1096 ± 99
|
0.056
|
2.762 (0.974–7.834)
|
|
High
|
740 ± 105
|
0.005
|
4.801 (1.606–14.350)
|
|
Platelets, ×109/L
|
CR (%)
| | |
|
< 38.5
|
78.6
| |
1.00 (reference)
|
|
≥ 38.5
|
92.2
|
0.006
|
3.225 (1.362–7.635)
|
|
Risk stratifications
|
Liver function damage (%)
|
0.009
| |
|
Low
|
22.9
| |
1.00 (reference)
|
|
Intermediate
|
5.9
|
0.008
|
0.213 (0.071–0.638)
|
|
High
|
15.1
|
0.355
|
0.660 (0.202–1.784)
|
|
Risk stratifications
|
Cardiotoxicity (%)
|
0.004
| |
|
Low
|
17.1
| |
1.00 (reference)
|
|
Intermediate
|
2.5
|
0.005
|
0.126 (0.030–0.535)
|
|
High
|
3.8
|
0.079
|
0.190 (0.036–1.001)
|
-
CR complete remission, OS overall survival, RFS relapse-free survival, CI confidence interval, HR hazard ratio, OR odd risk, SE standard error
